Menu Menu

RGLS    Regulus Therapeutics Inc    1505512    
Income Statement
Net Income rgls-20241231 -14,062,000

Balance Sheet
Current Assets 91,687,000
Assets 93,763,000
Current Liabilities 6,482,000
Liabilities 6,958,000
Equity 86,805,000

Cash Flow Statement
Operating Cash Flow -29,828,000
Investing Cash Flow -59,983,000

Market Analysis
BVPS 1.33
PB 1.06
PS 1.61
FCF -89,811,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2.49
Apr May Jun
5/09 -0.29
Jul Aug Sep
8/08 -0.17
Oct Nov Dec
11/7 -0.21

Find a discrepancy? The most accurate way to find company fundamental data is to view RGLS documents filed with the SEC.


RGLS Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas